Navigation Links
ChemoCentryx Reports Additional New Data from the PROTECT-1 Study Demonstrating Traficet-EN's Effectiveness in Maintaining Remission in Patients with Crohn's Disease
Date:12/7/2009

ions that may cause actual results, levels of activity, performance or achievements to differ materially from any results, levels of activity, performance or achievements expressed or implied by any forward-looking statement. Some of the risks, uncertainties and assumptions that could cause actual results to differ materially from estimates or projections contained in the forward-looking statements include but are not limited to (i) the initiation, timing, progress and results of ChemoCentryx's preclinical studies and clinical trials, (ii) ChemoCentryx's ability to advance product candidates into clinical trials, (iii) GSK's exercise of its license options, (iv) the commercialization of ChemoCentryx's product candidates, (v) the implementation of ChemoCentryx's business model, strategic plans for its business, product candidates and technology, (vi) ChemoCentryx's ability to maintain and establish collaborations or obtain additional government grant funding, (vii) ChemoCentryx's estimates of its expenses, future revenues, capital requirements and its needs for additional financing, (viii) the timing or likelihood of regulatory filings and approvals, (ix) the availability of corporate partners, (x) the scope of protection ChemoCentryx is able to establish and maintain for intellectual property rights covering its product candidates and technology, (xi) the impact of competitive products and technological changes, (xii) the availability of capital and the cost of capital, (xiii) ChemoCentryx's financial performance, (xiv) developments relating to ChemoCentryx's competitors and other vagaries in the biotechnology industry and (xv) other risks.

You are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date hereof. All forward-looking statements are qualified in their entirety by this cautionary statement and ChemoCentryx undertakes no obligation to revise or update this press release to reflect event
'/>"/>

SOURCE ChemoCentryx, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference
2. PROTECT-1 Phase II/III Induction-Stage Results for ChemoCentryxs Traficet-EN(TM) Presented in Oral Session at DDW 2009 Conference
3. ChemoCentryx Completes Enrollment of PROTECT-1, a Phase II/III Clinical Trial of CCR9 Antagonist CCX282-B (Traficet-EN(TM)) in Crohns Disease
4. ChemoCentryx Initiates Clinical Trial of CCR1 Inhibitor CCX354
5. Keryx Biopharmaceuticals, Inc. Reports Updated Phase 1/2 Data, Including New Survival Data, on KRX-0401 (Perifosine) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology
6. TaiGen Biotechnology Reports Phase I and Preclinical Data for TG-0054 at the 2009 American Society of Hematology (ASH) Annual Meeting
7. Quigley CEO, Ted Karkus, Announces Phase One of 2010 Strategic Plan; Karkus Reports that the Primary Focus will be on Leveraging its OTC Platform; Company Aggressively Seeking Product Acquisitions and Line Extensions which Leverage its Distribution
8. Dermagen Reports Successful Phase I/IIa Clinical Trial for Atopic Dermatitis
9. NOVAVAX Reports Positive Clinical Results from Pivotal Study of H1N1 Influenza Vaccine in Mexico
10. ADVENTRX Pharmaceuticals Reports Additional Pre-Clinical Data for ANX-514
11. Pharmasset Reports Fiscal Year End 2009 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/28/2015)... Research and Markets ... the "Craniomaxillofacial Implants Market - Global Industry ... - 2022" report to their offering. ... studies the current and future prospects of the ... in the global market due to increasing facial ...
(Date:7/28/2015)... , July 28, 2015  PD-Rx Pharmaceuticals, ... announced that it has partnered with Dobson Technologies, ... as a Service (IaaS) product. PD-Rx ... practices across the United States.  Using Dobson Technologies, ... recovery and business continuity, ensure regulatory compliance, and ...
(Date:7/28/2015)... WORTH, Texas , July 28, 2015 ... "Global Dermatology Devices Market by Type (Dermatology Treatment Devices, ... CT), Dermatoscopes, Microscopes]), by Application, by Geography - Analysis ... is expected to reach $11.88 billion by 2019, at ... Browse through the TOC of Global Dermatology Devices ...
Breaking Medicine Technology:Global Craniomaxillofacial Implants (Plate and Screw Fixator Systems, Bone Graft Substitutes, Distraction Systems, and TMJ Replacement Devices) Market Analysis 2014-2022 2PD-Rx Partners With Dobson Technologies 2Global Dermatology Devices Market to be Worth $11.88 Billion by 2019 2Global Dermatology Devices Market to be Worth $11.88 Billion by 2019 3
(Date:7/28/2015)... IL (PRWEB) , ... July 28, 2015 , ... ... of patented products, announces the Lost and Found, a breakthrough technological invention. ... network. , "Revenue for the consumer electronic industry reached a record high of ...
(Date:7/28/2015)... ... 2015 , ... Morristown Medical Center, part of Atlantic Health System, today announced ... hospitals in the nation, to implant the newly approved CoreValve® Evolut® R System from ... in good condition. , The CoreValve® Evolut® R System was approved by the U.S. ...
(Date:7/28/2015)... ... 28, 2015 , ... DuPont leaders today joined public and ... more about the impact of U.S. collaborations with local partners under the U.S. ... development as an engine of broad-based economic growth in the region. , ...
(Date:7/28/2015)... ... 28, 2015 , ... Women in Technology (WIT), the premier organization contributing to ... years, has selected Lisa Dezzutti, CEO and president at Market Connections, Inc. as the ... serve this organization that empowers women to thrive and excel in the technology field. ...
(Date:7/28/2015)... ... 28, 2015 , ... OrthAlign, Inc., a privately held medical ... a palm-sized, single-use navigation device for Total Hip Arthroplasty (cup placement, leg length, ... a revolutionary way for Total Knee Arthroplasty surgeries and is now doing it ...
Breaking Medicine News(10 mins):Health News:Getting Back to Basic with Bluetooth Is What the World Patent Marketing Review Team and Lost and Found Are All About 2Health News:Getting Back to Basic with Bluetooth Is What the World Patent Marketing Review Team and Lost and Found Are All About 3Health News:Getting Back to Basic with Bluetooth Is What the World Patent Marketing Review Team and Lost and Found Are All About 4Health News:Getting Back to Basic with Bluetooth Is What the World Patent Marketing Review Team and Lost and Found Are All About 5Health News:Morristown Medical Center First Hospital in New Jersey to Implant Newly Approved Heart Valve 2Health News:Morristown Medical Center First Hospital in New Jersey to Implant Newly Approved Heart Valve 3Health News:US President learns from DuPont Innovations in Food and Agriculture in Ethiopia 2Health News:US President learns from DuPont Innovations in Food and Agriculture in Ethiopia 3Health News:US President learns from DuPont Innovations in Food and Agriculture in Ethiopia 4Health News:Lisa Dezzutti Named President of Women in Technology (WIT) Board of Directors 2Health News:OrthAlign, Inc. Announces U.S. Commercial Launch of ORTHALIGN PLUS®, the most complete handheld navigation device for use in Total Hip Arthroplasty Surgery 2Health News:OrthAlign, Inc. Announces U.S. Commercial Launch of ORTHALIGN PLUS®, the most complete handheld navigation device for use in Total Hip Arthroplasty Surgery 3
... By Jenifer Goodwin HealthDay Reporter , WEDNESDAY, ... to prevent errors involving surgical patients dramatically reduced both ... Between 2007 and 2009, six hospitals in the Netherlands ... aspect of surgical care from the moment the patient ...
... United States population, are living with Chronic Kidney Disease ... trends continue, there will not be enough doctors to ... this crisis, the American Society of Nephrology (ASN) is ... upcoming ASN Renal Week 2010 in Denver, Colorado, on ...
... by scientists at the National Institute of Allergy ... of Health, sheds light on a poorly understood, ... that develops in some HIV-infected individuals soon after ... certain HIV-infected individuals whose immune systems are heavily ...
... HealthDay Reporter , WEDNESDAY, Nov. 10 (HealthDay News) ... patients, a dead body in a morgue, a baby confined ... other consequences of smoking that will appear on the outside ... habit or not starting in the first place, U.S. officials ...
... HealthDay Reporter , WEDNESDAY, Nov. 10 (HealthDay ... may have a slightly increased risk of developing colorectal ... therapy is often prescribed to treat prostate cancer. But ... two potential side effects, diabetes and obesity, are risk ...
... Nov. 11, 2010 New findings by researchers ... a brain chemical known to help regulate emotion, mood ... The findings, appearing online this week in ... why individuals prescribed certain kinds of anti-psychotic drugs that ...
Cached Medicine News:Health News:Hospital Checklists Reduce Surgical Complications, Deaths: Study 2Health News:Hospital Checklists Reduce Surgical Complications, Deaths: Study 3Health News:ASN leads efforts to address growing crisis in kidney care 2Health News:NIH scientists unveil mechanisms of immune reconstitution inflammatory syndrome 2Health News:FDA Proposes Graphic Warnings on Cigarette Packs 2Health News:FDA Proposes Graphic Warnings on Cigarette Packs 3Health News:Could a Prostate Cancer Treatment Raise Colon Cancer Risk? 2Health News:Could a Prostate Cancer Treatment Raise Colon Cancer Risk? 3Health News:Circuit regulating anti-diabetic actions of serotonin uncovered by UT Southwestern researchers 2
... factor I (IGF-I or somatomedin C) is a ... It acts as a potent mitogen of cellular ... cell-surface receptors. In the circulation, IGF-I is bound ... the actions of IGF-I by modulating the interaction ...
Urovac bladder evacuator with adaptor...
The Urology C-Arm Table features motorized actuation of height, X-Y, lateral roll and Trendelenburg motions of the tabletop, and is fully accessorized for urologic procedures....
... The UroVantage from HealthTronics ... the most versatile urology ... technological leap forward in ... for urologists by urologists, ...
Medicine Products: